A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

NCT04115423 · clinicaltrials.gov ↗

UNKNOWN

Status

9508

Enrollment

OTHER

Sponsor class

Conditions

Infection
Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)

Sponsor

Sungkyunkwan University

Collaborators

[object Object]